ADVENTRX Pharmaceuticals (ANX) Reports Q3 Loss of $0.07
Tweet
Share
E-mailGet Alerts ANX Hot Sheet
Price: $0.73 --0%
Financial Fact:
Total operating expenses: 7.25M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Total operating expenses: 7.25M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q3 EPS of ($0.07), versus ($0.13) reported last year.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
